Every year, 150 to 300 children in the United States are diagnosed with diffuse intrinsic pontine gliomas (DIPGs), aggressive and lethal tumors that grow deep inside the brain, for which there are no cures. In a study funded by the National Institutes of Health, researchers showed that experimental drugs designed to lower the body’s natural production of alpha-ketoglutarate extended the lives of mice harboring DIPG tumors by slowing the growth of the cancer cells.
- Ways to improve petroleum coke combustibility studied with presence of metal catalysts
- College students with disabilities at greater risk for substance abuse
- European survey shows alarmingly low awareness of erectile dysfunction
- Black women may be less likely to receive timely treatment for breast cancer
- COVID-19 and the decolonization of Indigenous public health